• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Bain Capital

Acquisitions
Pharma

Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma

After rumblings of a private equity bidding war last year, Bain Capital has emerged triumphant in its quest to acquire Mitsubishi Tanabe Pharma.
Fraiser Kansteiner Feb 7, 2025 11:26am
Hand passing wad of bills to other hand

CDMO Serán nabs $200M investment for commercial plant build-out

Sep 17, 2024 10:20am
for sale close down for sale sign business

Bain Capital eyes potential €1B Centrient sale: report

Jan 4, 2024 9:35am
French flag

French API maker Seqens primed for sale to the tune of $2.4B

Feb 10, 2021 7:30am
Lonza headquarters

CDMO Lonza will sell its speciality ingredients unit for $4.7B

Feb 9, 2021 8:59am
sale

GSK starts £1B OTC sell-off ahead of Pfizer merger: report

Jun 20, 2019 10:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings